Ensuring the Purity of Gene Therapy Products and Vaccines

Abstract

Get full access to this article

View all access options for this article.

References

Roberts

. Host Cell Protein Analysis: Is Above and Beyond Just Enough?. GEN . Published September 6, 2022. Accessed November 11, 2022. https://www.genengnews.com/topics/bioprocessing/host-cell-protein-analysis-is-above-and-beyond-just-enough/.

Herrera-Comoglio

, Lane

. Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine. N. Engl. J. Med . 2022; 387(15): 1431–1432. DOI: 10.1056/NEJMc2210813.

Cines

, Bussel

. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. N. Engl. J. Med. , 2021; 384(23): 2254–2256. DOI: 10.1056/NEJMe2106315.

Michalik

, Siegerist

, Palankar

, et al. Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines. Haematologica , 2022; 107(4): 947–957. DOI: 10.3324/haematol.2021.280154.

Mortz

. Analyzing vaccine purity—without an HCP ELISA [webinar]. Alphalyse. https://www.alphalyse.com/customer-support/webinars/webinar-vaccine-analysis/. Accessed November 2, 2022.

SCIEX. SWATH Acquisition, Ensuring Nothing Is Missed. https://sciex.com/technology/swath-acquisition. Accessed November 2, 2022.